ACTsocially: Using Acceptance and Commitment Therapy to help teens with social anxiety and oppositional behavior
Official title: ACTsocially: The (Dis)Similarities of ACT for Changing Internalizing and Externalizing Symptomatology in Adolescence
Run by University of Coimbra · NCT07456631 · Data updated 2026-11-12
This project will test whether a transdiagnostic Acceptance and Commitment Therapy (ACT) program can reduce social anxiety and oppositional defiant behaviors in adolescents who have both conditions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 18 Years |
| Sex | All |
| Enrollment | 54 (estimated) |
| Sponsor | University of Coimbra Academic / other |
| Locations | 1 site (Coimbra) |
| Status | Recruiting |
| Started | September 1, 2023 |
| Main results expected | September 30, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | March 10, 2026 |
| Trial ID | NCT07456631 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adolescents whose main diagnosis is ODD (and who also meet criteria for SAD) or whose main diagnosis is SAD (and who also meet criteria for ODD), who are not currently receiving another psychological treatment, are the intended participants.
✕Probably not a fit
Adolescents with autism spectrum disorder, active psychotic symptoms, significant cognitive impairment, or those already enrolled in psychological treatment may be excluded and are less likely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project runs three interventional trials delivering a transdiagnostic ACT program (ACTsocially) to adolescents with primary Oppositional Defiant Disorder who meet criteria for Social Anxiety Disorder, and to adolescents with primary Social Anxiety Disorder who meet criteria for Oppositional Defiant Disorder. Eligible participants are adolescents meeting diagnostic criteria for the target disorders; those with autism spectrum disorder, psychotic symptoms, impaired cognitive development, or who are currently in another psychological intervention are excluded. Outcomes include changes in internalizing and externalizing symptoms and measures of psychological flexibility to compare whether ACT produces similar or different effects across presentations. The intervention is delivered by the research team at the University of Coimbra with follow-up assessments across the treatment period.
Why it matters
Potential benefit: If successful, the program could reduce anxiety and oppositional behaviors and improve peer relationships and daily functioning for adolescents.
How similar studies have gone: ACT has shown benefit for internalizing and externalizing symptoms in adult samples, but randomized adolescent trials of a transdiagnostic ACT targeting both ODD and SAD are limited, making this application relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Study I: * Main diagnosis of Oppositional Defiant Disorder (ODD) * Meeting diagnostic criteria for Social Anxiety Disorder (SAD) Study II: * Main diagnosis of Social Anxiety Disorder (SAD) * Meeting diagnostic criteria for Oppositional Defiant Disorder (ODD) Exclusion Criteria (applies to both studies): * Impaired cognitive development based on school records * Presence of psychotic symptoms according to the diagnostic interview * Diagnosis of autism spectrum disorder according to the diagnostic interview * Currently undergoing another psychological intervention for a psychiatric condition Note: Comorbid conditions other than the co-occurrence of ODD and SAD will not be considered exclusion criteria.
Where it's running
-
Fpceuc
Coimbra, Portugal Recruiting
Study contacts
- Study coordinator: Francisca Alves M.Sc.
- Email: mfrancisca.mca@gmail.com
- Phone: +351 914309297
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Caplyta versus placebo for adults with social anxiety disorder
This study tests whether Caplyta works better than a placebo for adults with social anxiety disorder over 8 weeks.
-
Augmenting Parent Management Training with a Smartphone Tool
This study tests whether adding a smartphone app to parent management training helps reduce irritability and temper outbursts in kids aged 8–13 with disruptive behavior disorders.
-
Expectancy Focused Exposure for Anxiety Disorders
We test whether Expectancy Focused Exposure helps reduce anxiety symptoms and prevent fear from coming back better than Anxiety Focused Exposure in adults with anxiety disorders.
-
Attention Bias Modification for Social Anxiety Disorder: Does training help, or is it a placebo effect?
This study tests whether a computerized attention training (ABM) reduces social anxiety symptoms in adults with SAD, and whether any improvement comes from actual attentional changes or from placebo/expectancy factors.
-
Therapy approaches for irritability in youths: active treatments vs nonactive psychoeducation
This study tests whether active psychotherapies for irritability in kids aged 8–16.5 years work better than nonactive, time-matched psychoeducation for children and their parents.
-
Short bursts of noninvasive brain stimulation to the prefrontal cortex for social anxiety
This treatment will test whether daily intermittent theta-burst brain stimulation to the prefrontal cortex can reduce social anxiety symptoms in people with SAD while tracking brain changes with EEG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.